Skip to main content

Market Overview

Mizuho Securities Downgrades Auxilium Pharmaceuticals To Neutral


Analysts at Mizuho Securities downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.

The price target for Auxilium Pharmaceuticals has been lowered from $37.00 to $33.00.

Auxilium Pharmaceuticals shares have climbed 87.41% over the past 52 weeks, while the S&P 500 index has gained 13.21% in the same period.

Auxilium Pharma shares jumped 9.01% to close at $32.44 yesterday.

Latest Ratings for AUXL

Oct 2014MizuhoDowngradesBuyNeutral
Oct 2014MKM PartnersDowngradesBuyNeutral
Sep 2014RBC CapitalDowngradesOutperformSector Perform

View More Analyst Ratings for AUXL
View the Latest Analyst Ratings


Related Articles (AUXL)

View Comments and Join the Discussion!

Posted-In: Mizuho SecuritiesDowngrades Analyst Ratings

Latest Ratings

ICADGuggenheimInitiates Coverage On24.0
SMBKRaymond JamesUpgrades27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at